Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06703762

Efficacy of Photobiomodulation on Wound Healing and Il-6 in Neuropathic Foot Ulcer

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
50 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to detect the effect of Laser Photobiomodualation on the wound healing and Il-6 in neuropathic foot ulcer.

Detailed description

Wound healing is a complex, interactive, and integrative event, involving cellular and chemotactic activity with release of chemical mediators associated with vascular responses and cell proliferation. It consists in a sequence of events leading to the closure of dermal injuries. The repair follows steps of inflammation, re-epithelization, wound contraction, and matrix remodeling. The healing process can be influenced by various local and systemic factors. The ulcer treatment in the diabetic foot requires a multidisciplinary approach, including revascularization and surgical procedures, as well as the infection treatment, physiotherapeutic rehabilitation with electric phototherapeutic resources to control edema, pain, metabolic disorders, tissue malnutrition, co morbidities, precise treatment of the wound and biomechanics' decompression that will help in amputation prevention. Biophotomodulation in the form of Low level laser (LLL) irradiation can promote cell migration and cell proliferation by stimulating mitochondrial activity and maintaining viability without causing damage to the wounded cells. The usage of LLLT presents itself as being a new therapeutic proposal, seeking the cure of these injuries, the improvement on the quality of life of the affected individuals, as well as the reduction of the costs of the treatment in the health system, this study aims to identify the effects of low-level laser therapy on neuropathic foot ulcer healing and the effect of LLL on the hyperglycemic-induced inflammatory response in IL-6 and sought to identify which pathway it might achieve this effect.

Conditions

Interventions

TypeNameDescription
OTHERHe-Ne low level laser (LLL)Patients in the experimental group will receive treatment with LLLT. The ulcer bed will be irradiated locally with red light (660 nm). The ulcer size and its depth will be used as the basis to calculate the duration of exposure needed to deliver 3-10 J/cm² for 15 to 20 minutes. The application will take place in 3 sessions per week for 4 weeks. Each patient will be asked to lie in a supine position with the ulcer easily exposed to the laser beam, and they will be instructed to wear laser glasses and avoid looking directly at the beam until the end of the session.
OTHERConventional traditional treatmentAll patients in both the groups will receive the required, conventional treatments of diabetic wound care, including dressing, antibiotics, controlling diabetes, cholesterol, and blood pressure along with aggressive drug treatment and wound debridement when needed.

Timeline

Start date
2024-11-26
Primary completion
2025-01-26
Completion
2025-02-01
First posted
2024-11-25
Last updated
2024-11-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06703762. Inclusion in this directory is not an endorsement.